A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1462 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-06

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study

NCT00334724

Cardiovascular Disease Vascular Disease Hypertension

WITHDRAWN PHASE4

Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers

NCT01460732

Hypertension

COMPLETED NA

Home Blood Pressure Intervention in the Community Trial

NCT05858944

Home Blood Pressure

RECRUITING NA

Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)

NCT04212468

Blood Pressure

RECRUITING

Home Blood Pressure (HBP)-Guided Management of Hypertension in Stage 3-4 CKD

NCT03588520

Hypertension Chronic Kidney Diseases

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

The main purpose of this study is to:

* Assess HBP control status in each Asian country
* Develop an Asian consensus and Asia-specific treatment for hypertension
* Improve the management of hypertension in Asia by encouraging patients to monitor HBP

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

home blood pressure measurement

We ask participants to measure their home blood pressure 7 days or more.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age \>= 20 years
2. Subjects with stable medication (\> 3 months) diagnosed as hypertension
3. Asian
4. Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.